Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Allory

Showing results (51-60 of 230) with videos related to

Pageof 23
Sort By:
European Urology|September 6, 2005
What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?Aurélien Descazeaud, Mark A Rubin, Yves Allory, et al.
Proteomics|March 11, 2014
Prediction of recurrence of non muscle-invasive bladder cancer by means of a protein signature identified by antibody microarray analysesHarish Srinivasan, Yves Allory, Martin Sill, et al.
Urologic Oncology|July 19, 2017
Predictive factors for final pathologic ureteral sections on 700 radical cystectomy specimens: Implications for intraoperative frozen section decision-makingAlexandra Masson-Lecomte, Thomas Francois, Dimitri Vordos, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 5, 2003
Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor betaAlexandre Hertig, Jeannig Berrou, Yves Allory, et al.
Urology|September 3, 2008
Laparoscopic radical prostatectomy after transurethral resection of the prostate: surgical and functional outcomesJohann Menard, Alexandre de la Taille, Andras Hoznek, et al.
European Urology|August 18, 2009
The role of biopsy core number in selecting prostate cancer patients for active surveillanceGuillaume Ploussard, Evanguelos Xylinas, Laurent Salomon, et al.
The Journal of Urology|December 17, 2009
Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria?Guillaume Ploussard, Laurent Salomon, Evanguelos Xylinas, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 23, 2015
International Prostate Symptom Score is a predictive factor of lower urinary tract symptoms after radical prostatectomyYounes Bayoud, Alexandre de la Taille, Adil Ouzzane, et al.
Molecular & Cellular Oncology|June 17, 2016
Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancersThierry Lebret, Yann Neuzillet, Nadine Houede, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2019
Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancerMathieu Rouanne, Reem Betari, Camélia Radulescu, et al.
Pageof 23

Showing results (51-60 of 230) with videos related to

Sort By:
Pageof 23
European Urology|September 6, 2005
What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?Aurélien Descazeaud, Mark A Rubin, Yves Allory, et al.
Proteomics|March 11, 2014
Prediction of recurrence of non muscle-invasive bladder cancer by means of a protein signature identified by antibody microarray analysesHarish Srinivasan, Yves Allory, Martin Sill, et al.
Urologic Oncology|July 19, 2017
Predictive factors for final pathologic ureteral sections on 700 radical cystectomy specimens: Implications for intraoperative frozen section decision-makingAlexandra Masson-Lecomte, Thomas Francois, Dimitri Vordos, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 5, 2003
Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor betaAlexandre Hertig, Jeannig Berrou, Yves Allory, et al.
Urology|September 3, 2008
Laparoscopic radical prostatectomy after transurethral resection of the prostate: surgical and functional outcomesJohann Menard, Alexandre de la Taille, Andras Hoznek, et al.
European Urology|August 18, 2009
The role of biopsy core number in selecting prostate cancer patients for active surveillanceGuillaume Ploussard, Evanguelos Xylinas, Laurent Salomon, et al.
The Journal of Urology|December 17, 2009
Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria?Guillaume Ploussard, Laurent Salomon, Evanguelos Xylinas, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 23, 2015
International Prostate Symptom Score is a predictive factor of lower urinary tract symptoms after radical prostatectomyYounes Bayoud, Alexandre de la Taille, Adil Ouzzane, et al.
Molecular & Cellular Oncology|June 17, 2016
Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancersThierry Lebret, Yann Neuzillet, Nadine Houede, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2019
Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancerMathieu Rouanne, Reem Betari, Camélia Radulescu, et al.
Pageof 23